ADENOVIRAL EXPRESSION OF HUMAN LCAT IN NON-HUMAN PRIMATES LEADS TO AN ANTI-ATHEROGENIC LIPOPROTEIN PHENOTYPE BY INCREASING HDL AND LOWERING LDL

Lecithin:cholesterol acyltransferase (LCAT), a key enzyme in HDL metabolism, has been proposed to have atheroprotective properties, by promoting reverse cholesterol transport. Over expression of LCAT in various animal models, however, has led to conflicting results on its overall effect on lipoprote...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Amar, M.J.A, Shamburek, R.D, Vaisman, B., Knapper, C, Foger, B., Hoyt, R.F., Fojo, S.S, Brewer, B.H., Remaley, T.A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3703629/
https://ncbi.nlm.nih.gov/pubmed/19303980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.metabol.2008.11.019
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky